REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Avangard OOO (Novosibirsk) (Russia)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Avangard OOO Profile Updated: August 17, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Russian Download a sample report

Avangard OOO (Novosibirsk) is based in Russia. The head office is in Novosibirsk. The enterprise operates in the Pharmaceutical and Medicine Manufacturing industry. The enterprise was incorporated on July 14, 2014. The total number of employees is currently 10 (2022). The latest financial highlights indicate a net sales revenue increase of 30.5% in 2023. Over the same period, its total assets grew by 22.19%. The net profit margin of Avangard OOO (Novosibirsk) increased by 8.12% in 2023.

Headquarters
Planetnaya, 30, 1
Novosibirsk; Novosibirsk Oblast; Postal Code: 630015

Contact Details: Purchase the Avangard OOO (Novosibirsk) report to view the information.

Basic Information
Total Employees:
Purchase the Avangard OOO (Novosibirsk) report to view the information.
Outstanding Shares:
Purchase the Avangard OOO (Novosibirsk) report to view the information.
Registered Capital:
Purchase the Avangard OOO (Novosibirsk) report to view the information.
Incorporation Date:
July 14, 2014
Key Executives
Purchase this report to view the information.
General Director
Ownership Details
Purchase this report to view the information.
50%
Purchase this report to view the information.
50%
Company Performance
Financial values in the chart are available after Avangard OOO (Novosibirsk) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RUB. Absolute financial data is included in the purchased report.
Net sales revenue
30.5%▲
Total operating revenue
30.5%▲
Operating profit (EBIT)
152.89%▲
Net Profit (Loss) for the Period
188.4%▲
Total assets
22.19%▲
Total equity
121.93%▲
Operating Profit Margin (ROS)
9.32%▲
Net Profit Margin
8.12%▲
Return on Equity (ROE)
12.67%▲
Debt to Equity Ratio
-70.54%▼
Quick Ratio
10.34%▲
Cash Ratio
7.13%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo